Indeed, it is well known that chronic GVHD (and its treatment) has a profound impact on immunity after allo-HCT, affecting many cell subtypes such as B cells, CD4+ T cells, naive CD4+ T cells, TfH and CD8+ T cells [8, 23, 24]. The gene discussed is CD8A; the disease is chronic graft versus host disease.